Trailing-twelve-month (TTM) revenue is $2.04 Billion with a year-over-year growth of (18.95%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $454,100,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $611,200,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-19 |
| Q1 FY2026Period ended 2026-03-31 | $492,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-30 | $485,100,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-30 |
| TTM revenue | $2,042,400,000 |
Current P/S: $2,270,580,351 market capitalization ÷ $2,042,400,000 TTM revenue = 1.11x.
Market capitalization source: FMP quote. Quote observed 2026-09-11T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $485.10M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:16:09.034Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2017-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Leasing | $802M | $735M | $770M | $870M | N/A | N/A |
| Manufacturing | $1.2B | $781M | $1.2B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20122012-12-31 · USD | FY20132013-12-31 · USD | FY20142014-12-31 · USD | FY20152015-12-31 · USD | FY20162016-12-31 · USD | FY20172017-12-31 · USD |
|---|---|---|---|---|---|---|
| MEXICO | $96M | $134M | $130M | $337M | $318M | $263M |
$2.04B
$2.04 Billion
(18.95%)
vs. $2.52B a year ago (TTM)
+6.38%
5 Year compound annual growth rate
1 Year
(18.95%)
3 Year
(5.91%)
5 Year
+6.38%
10 Year
(9.37%)
15 Year
(1.46%)
20 Year
(2.17%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $2.16B | ($922.30M) | (29.95%) |
| 2024 | $3.08B | +$95.90M | +3.21% |
| 2023 | $2.98B | +$1.01B | +50.88% |
| 2022 | $1.98B | +$461.30M | +30.43% |
| 2021 | $1.52B | ($233.70M) | (13.36%) |
| 2020 |
TTM Growth
(18.95%)
3-Year CAGR
(5.91%)
5-Year CAGR
+6.38%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-12T00:16:09.034Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
| $1.9B |
| $952M |
| $1.75B |
| ($1.00B) |
| (36.43%) |
| 2019 | $2.75B | +$243.30M | +9.70% |
| 2018 | $2.51B | ($1.15B) | (31.50%) |
| 2017 | $3.66B | ($925.50M) | (20.17%) |
| 2016 | $4.59B | ($1.80B) | (28.23%) |
